PMDA drug package insert
静注用フローラン0.5mg
PMDA Prescription drug · グラクソ・スミスクライン株式会社 · package insert Aug 8, 2025
Key facts
| Brand names | 静注用フローラン0.5mg, 静注用フローラン1.5mg, 静注用フローラン専用溶解液 |
|---|---|
| Nonproprietary names | エポプロステノールナトリウム, エポプロステノールナトリウム専用溶解液 |
| Companies | 製造販売元／グラクソ・スミスクライン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | プロスタグランジンI2製剤 |
| Therapeutic category codes | 87219 |
| YJ codes | 2190413F2024, 2190413F1028, 2190413F3020, 2190413F4027, 2190415A1020 |
| Approval numbers | 21100AMY00016, 21300AMY00082 |
| Package insert edition | 第6版 |
| Package insert date | Aug 8, 2025 |
| PMDA document key | 340278_2190413F1028_W |
| PMDA company code | 340278 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: